SOURCE: Cambridge Healthtech Institute

Cambridge Healthtech Institute

April 15, 2016 10:30 ET

Plenary Keynotes & Speaker Lineup Announced for World Preclinical Congress 2016

Anthony J. Coyle Ph.D., of Pfizer Inc. and James Wilson, M.D., Ph.D., of University of Pennsylvania to Speak on This Year's Agenda

NEEDHAM, MA--(Marketwired - April 15, 2016) - Cambridge Healthtech Institute (CHI) announced the speaker agenda for the 15th Annual World Preclinical Congress, taking place June 14-17, 2016 in Boston, MA. The leading preclinical drug discovery event, the World Preclinical Congress, features conferences, training seminars and short courses that cover the very latest in preclinical strategies and technologies, to enable better and faster decisions in drug discovery.

This annual event is where preclinical minds meet discovery technologies, and this event attracts a diverse, global audience, which include experts, as well as people who are new and eager to contribute to the field. Having chemists, biologists, pharmacologists, toxicologists, screening and formulation experts in attendance, creates an interesting cross-disciplinary environment for tackling challenges and sharing expertise.

The Plenary Keynote Presentations feature two prominent thought-leaders who are playing an important role in innovating drug discovery: Anthony J. Coyle Ph.D., Chief Scientific Officer and Senior Vice President, Centers for Therapeutic Innovation, Pfizer Inc. and James Wilson, M.D., Ph.D., Professor, Department of Pathology and Laboratory Medicine, Perelman School of Medicine; Director, Orphan Disease Center and Director, Gene Therapy Program, University of Pennsylvania. During the keynote presentations, Coyle and Wilson will share their experiences and their perspectives on what has changed and what can be changed to improve preclinical research, help translate preclinical findings to the clinic, and to foster effective communication and collaboration. Attendees will have an opportunity to ask questions and gain valuable insights from their learnings.

Coyle and Wilson will join a distinguished faculty list comprised of over 220 world-renowned experts and visionaries in the drug discovery community.

The year's event features nearly 175 presentations within twelve topic-focused conferences, two symposia, an introductory training seminars, over 65 exhibiting companies, scientific research posters, interactive roundtable discussions and a plethora of engaging networking events.

For more information about the World Preclinical Congress, visit: www.WorldPreclinicalCongress.com.

About Cambridge Healthtech Institute (www.healthtech.com)
Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Preclinical Congress, Next Generation Dx Summit and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Knowledge Foundation, Bio-IT World, Clinical Informatics News and Diagnostics World.

Contact Information